Management Change/Compensation (Form 8-K)

Item 5.02 Departure of Director and Election of Director

On April 1, 2026, Bioscience Health Innovations, Inc. (the "Company") announced that Justin Earl has resigned from the Company's Board of Directors, effective immediately. Mr. Earl's resignation was not the result of any disagreement with the Company on any matter relating to its operations, policies, or practices.

The Company also announced that, on April 1, 2026, the Board of Directors appointed Mr. Daniel Schmidt to serve as a director, effective immediately, to fill the vacancy created by Mr. Earl's resignation.

Prior to Mr. Schmidt's appointment, he has been serving as the Company's Chief Technology Officer since the Company's inception.

Dan has extensive experience in therapeutic medical devices and treatments including, Radio Frequency, Stem Cells, Laser and Ultrasound Technologies, Non-Surgical Skin Tightening and Fat Reduction. Mr. Schmidt has invested the last 26 years seeking ways to improve people's quality of life by developing and commercializing innovative healthcare products and services.